- TARGETED COMMUNITY ALTERNATIVES TO PRISON (TCAP) AND LOCAL OPIOID SETTLEMENT GOVERNMENT FUND (LOSGF)
JUSTICE GRANTS: The Franklin County Office of Justice Policy and Programs (OJPP) is pleased to announce the availability of funding through the Joint FY2024 Targeted Community Alternatives to Prison (TCAP) and FY2024 Local Opioid Settlement Government Fund (LOSGF) grant programs. To streamline the RFP process, applicants have the option of applying for TCAP, LOSGF, or both grant programs; however, may only submit one application under each grant. Interested applicants can access the RFP guidance and application template by visiting the OJPP website. The deadline for application submission is 11:59 pm on November 20, 2023.
- FRANKLIN COUNTY OFFICE OF JUSTICE POLICY AND PROGRAMS (OJPP)
Availability of funding through the FY 2022 Title II Juvenile Justice and Delinquency Prevention grant program.
Interested applicants can access the RFP guidelines and application template by visiting the OJPP website at FranklinCountyOhio.gov/Grants. The deadline for application submission is 11:59 PM on November 30, 2023.
- GOVERNOR DEWINE APPROVES $4 MILLION GRANT FOR DIVERSION PROGRAM TRAINING, TECHNICAL ASSISTANCE AT NEOMED
Ohio Governor Mike DeWine today announced a $4 million grant for Northeast Ohio Medical University (NEOMED) to provide training and technical assistance for communities developing or implementing deflection and pre-arrest diversion programs to help those with substance use disorder get the help and treatment they need.
- OHIO HOUSE PASSES BILL TO DECRIMINALIZE FENTANYL TEST STRIPS
Fentanyl testing strips would be decriminalized under a bill the Ohio House passed Wednesday with overwhelming bipartisan support, advancing a proposal that proponents say would help prevent fatal overdoses and save lives.
- OFFICE OF NATIONAL DRUG CONTROL POLICY (ONDCP), “MODEL DEFLECTION ACT”
This project was supported by Grant No. G1999ONDCP03A awarded by the Office of National Drug Control Policy, Executive Office of the President. Points of view or opinions in this document are those of the author and do not necessarily represent the official position or policies of the Office of National Drug Control Policy or the United States Government.